Farmak JSC added Nalbuk, a drug for treatment of pain syndrome, to its product portfolio. The new drug is manufactured in the form of solution for injection in 1 or 2 ml ampoule No. 5 or 1 ml syringe No. 5.
Nalbuk is developed on the basis of the active substance nalbuphine. The product is used for treatment of moderate to severe pain. In addition, Nalbuk is recommended for use as a supplementary analgesic drug, to relieve pain during pre- and postoperative period, and for childbirth anesthesia.
